Henriette U. Balinda, PhD

Research Scientist
UT Health San Antonio

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 186Rhenium-Nanoliposomes (186RNL) for the Treatment of Leptomeningeal Metastases: Translational Insights From Clinical and Preclinical Models

  Saturday, May 2, 2026
  10:44 AM - 10:52 AM CT